Commonly-Prescribed Antidepressant Recalled Over Potential Carcinogen: FDA

By The Epoch Times | Created at 2026-06-15 19:01:50 | Updated at 2026-06-16 05:24:51 10 hours ago
 FDA

The Food and Drug Administration headquarters in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

A commonly used prescription antidepressant medication is being recalled because it may contain a carcinogenic substance, the Food and Drug Administration announced.

New Jersey-based Breckenridge Pharmaceutical, Inc., is recalling 14,729 bottles of duloxetine delayed-release capsules in 30-milligram doses, contained in 1,000-count bottles, according to a notice that was published on the FDA’s recall database this week. The medication has an expiration date of April 2027 with a lot number of 241180C.

Read Entire Article